NCT04025216 2024-01-24A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced CancersGilead SciencesPhase 1 Terminated16 enrolled
NCT02785250 2021-06-18Study of DPX-Survivac Therapy in Patients With Recurrent Ovarian CancerImmunoVaccine Technologies, Inc. (IMV Inc.)Phase 1/2 Unknown85 enrolled
NCT01416038 2017-04-21Phase 1 Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal CancerImmunoVaccine Technologies, Inc. (IMV Inc.)Phase 1 Completed19 enrolled